We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
+12.54%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.02%
AUM
$8.03B
AUM Growth
+$505M
Cap. Flow
-$223M
Cap. Flow %
-2.78%
Top 10 Hldgs %
12.3%
Holding
1,464
New
99
Increased
306
Reduced
315
Closed
129

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$52.5M
2
DIS icon
Walt Disney
DIS
+$50.9M
3
O icon
Realty Income
O
+$46M
4
QCOM icon
Qualcomm
QCOM
+$43.6M
5
CHD icon
Church & Dwight Co
CHD
+$35.2M

Top Sells

Rank Stock Value
1
KO icon
Coca-Cola
KO
+$58.8M
2
TGT icon
Target
TGT
+$46.7M
3
EMN icon
Eastman Chemical
EMN
+$43.1M
4
AGN
Allergan plc
AGN
+$41.1M
5
MRO
Marathon Oil Corporation
MRO
+$41.1M

Sector Composition

Rank Sector Weight
1 Financials 24.51%
2 Technology 12.33%
3 Healthcare 11.26%
4 Consumer Discretionary 11.18%
5 Industrials 10.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CYPH
1301
Cypherpunk Technologies Inc
CYPH
$73.5M
$68K ﹤0.01%
3,630
ELGX
1302
DELISTED
Endologix Inc
ELGX
$66K ﹤0.01%
10,000
-27,500
-73% -$181K
ARTW icon
1303
Arts-Way Manufacturing Co
ARTW
$11.5M
$62K ﹤0.01%
30,000
CATX icon
1304
Perspective Therapeutics
CATX
$342M
$62K ﹤0.01%
16,870
MYO icon
1305
Myomo
MYO
$41.7M
$60K ﹤0.01%
+1,667
New +$71K
ADYX
1306
DELISTED
Adynxx Inc
ADYX
$60K ﹤0.01%
+3,417
New +$50.8K
MXC icon
1307
Mexco Energy
MXC
$18M
$59K ﹤0.01%
12,000
SACH
1308
Sachem Capital Corp
SACH
$40M
$57K ﹤0.01%
+12,600
New +$54K
NOVN
1309
DELISTED
Novan, Inc. Common Stock
NOVN
$57K ﹤0.01%
6,000
NH
1310
DELISTED
NantHealth, Inc
NH
$56K ﹤0.01%
4,060
IRD
1311
Opus Genetics
IRD
$306M
$53K ﹤0.01%
2,148
SYPR icon
1312
Sypris Solutions
SYPR
$46.3M
$52K ﹤0.01%
46,404
KG
1313
Kestrel Group
KG
$70.5M
$46K ﹤0.01%
3,130
-5,715
-65% -$132K
ZNB
1314
Zeta Network Group
ZNB
$2.57M
0
SIF icon
1315
SIFCO Industries
SIF
$173M
$44K ﹤0.01%
16,024
GNMX
1316
DELISTED
Aevi Genomic Medicine Inc
GNMX
$44K ﹤0.01%
223,500
MBIO icon
1317
Mustang Bio
MBIO
$4.5M
$43K ﹤0.01%
17
-66
-80% -$187K
YOGA
1318
DELISTED
YogaWorks, Inc. Common Stock
YOGA
$43K ﹤0.01%
47,000
SGRP
1319
DELISTED
SPAR Group
SGRP
$42K ﹤0.01%
63,000
FRTX
1320
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
$42K ﹤0.01%
110
-168
-60% -$56.3K
NVIV
1321
DELISTED
InVivo Therapeutics Holdings Corp
NVIV
$39K ﹤0.01%
33
-2
-6% -$2.32K
QRHC icon
1322
Quest Resource Holding
QRHC
$26.1M
$36K ﹤0.01%
22,000
ITP icon
1323
IT Tech Packaging
ITP
$3.08M
$35K ﹤0.01%
3,500
MDLY
1324
DELISTED
Medley Management Inc
MDLY
$34K ﹤0.01%
1,000
PZG icon
1325
Paramount Gold Nevada
PZG
$104M
$33K ﹤0.01%
40,000

Similar funds

Bridgeway Capital Management's Q1 2019 Portfolio in Review

As of Q1 2019, Bridgeway Capital Management held 1,464 positions worth $8.03B, up 6.7% from $7.53B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Bridgeway Capital Management's Q1 2019 filing shows 99 new, 306 increased, 315 reduced and 129 closed positions. Its largest new stake was Realty Income: 694,072 shares worth $49.5M. The largest sale was Coca-Cola, an estimated $58.8M.

By sector, the portfolio is most concentrated in Financials at 25% of assets, up from 24% a quarter earlier, followed by Technology and Healthcare.

  • Bridgeway Capital Management's largest Q1 2019 buy was Realty Income: 694,072 shares worth $49.5M.
  • Bridgeway Capital Management added most to Microsoft in Q1 2019, an estimated $52.5M increase.
  • Bridgeway Capital Management's biggest Q1 2019 reduction was Coca-Cola, cutting an estimated $58.8M.
  • Bridgeway Capital Management fully exited Target in Q1 2019, selling an estimated $46.7M.
  • Bridgeway Capital Management's ten largest holdings make up 12% of its $8.03B portfolio in Q1 2019.
  • Bridgeway Capital Management opened 99 new positions and closed 129 in Q1 2019.
  • Bridgeway Capital Management's portfolio value rose 6.7% quarter-over-quarter to $8.03B.

Based on Bridgeway Capital Management's 13F filing for Q1 2019, filed 15 May 2019.